Maga P et al. |
11-dehydro thromboxane B2 levels after percutaneous transluminal angioplasty in patients with peripheral arterial occlusive disease during a one year follow-up period. |
2016 |
J. Physiol. Pharmacol. |
pmid:27511998
|
Kakouros N et al. |
Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery. |
2016 |
J Am Heart Assoc |
pmid:27068626
|
Santilli F et al. |
Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding. |
2016 |
Circ. J. |
pmid:26632534
|
Liu TF et al. |
[Correlation between the level of the urinary 11-dehydrothromboxane B2 and the clinical efficacy of aspirin in patients with type 2 diabetes and coronary artery disease]. |
2015 |
Beijing Da Xue Xue Bao |
pmid:26679651
|
Lüdicke F et al. |
A Japanese cross-sectional multicentre study of biomarkers associated with cardiovascular disease in smokers and non-smokers. |
2015 |
Biomarkers |
pmid:26616146
|
Di Minno MN et al. |
Increased platelet reactivity in Klinefelter men: something new to consider. |
2015 |
Andrology |
pmid:26216452
|
Véricel E et al. |
Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients. |
2015 |
Thromb. Haemost. |
pmid:25832443
|
Ross S et al. |
Association of cyclooxygenase-2 genetic variant with cardiovascular disease. |
2014 |
Eur. Heart J. |
pmid:24796340
|
DeFilippis AP et al. |
Fatty acids and TxA(2) generation, in the absence of platelet-COX-1 activity. |
2014 |
Nutr Metab Cardiovasc Dis |
pmid:24370448
|
Gonçalves LH et al. |
Acetylsalicylic acid therapy: influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels. |
2014 |
Clin. Chim. Acta |
pmid:24316050
|
Floyd CN et al. |
Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. |
2014 |
Br J Clin Pharmacol |
pmid:25099258
|
Lattanzio S et al. |
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. |
2014 |
J Am Heart Assoc |
pmid:25037197
|
Santilli F et al. |
Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment. |
2014 |
J Am Heart Assoc |
pmid:25037196
|
Dudley A et al. |
Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirin. |
2013 Jan-Feb |
J. Vet. Intern. Med. |
pmid:23278865
|
Gremmel T et al. |
Differential impact of inflammation on six laboratory assays measuring residual arachidonic acid-inducible platelet reactivity during dual antiplatelet therapy. |
2013 |
J. Atheroscler. Thromb. |
pmid:23739624
|
Nakamura A et al. |
Oral administration of a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity for pulmonary arterial hypertension. |
2013 |
Circ. J. |
pmid:23676973
|
Vazzana N et al. |
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype. |
2013 |
J Am Heart Assoc |
pmid:23557750
|
DeFilippis AP et al. |
Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. |
2013 |
Circ. J. |
pmid:23985963
|
Kapłon-Cieślicka A et al. |
Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. |
2013 |
Kardiol Pol |
pmid:24065375
|
d'Emmanuele di Villa Bianca R et al. |
Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24019484
|